Overview
UPB market data
Price History
UPB price chart · 1M
- O
- 7.08
- H
- 7.08
- L
- 6.81
- C
- 6.83
- Vol
- 10,626.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $7.08
- Previous Close
- $7.13
- Day High
- $7.08
- Day Low
- $6.81
- 52 Week High
- $9.57
- 52 Week Low
- $5.86
- 7 Day Return
- -0.36%
- 30 Day Return
- +6.64%
- 90 Day Return
- -18.25%
- 1 Year Return
- -25.60%
- Daily Notional Volume
- $72.6K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.66 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.07 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4,719.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $5.85 – $33.68 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $385.8M · P/B 4.32 · P/S 116.15.
Company News
JP Morgan Maintains Neutral on Upstream Bio, Raises Price Target to $9Benzinga · Aug 14, 2026, 4:14 PM
Truist Securities Maintains Buy on Upstream Bio, Lowers Price Target to $25Benzinga · Aug 12, 2026, 5:39 PM
Upstream Bio Q2 EPS $(0.73) Beats $(0.76) Estimate, Sales $773.000K Beat $430.714K EstimateBenzinga · Aug 11, 2026, 11:33 AM
8-K filing — Upstream Bio, Inc. (UPB)SEC EDGAR · Aug 11, 2026, 11:05 AM
JP Morgan Downgrades Upstream Bio to Neutral, Lowers Price Target to $8Benzinga · Jun 12, 2026, 1:20 PM
Upstream Bio to Present New Verekitug Data at EAACI 2026, Phase 2 Nasal Polyps Analysis Gets EAACI Oral PresentationBenzinga · Jun 8, 2026, 11:30 AM